Sinclair Pharma (SPH)

 

SPH Share PerformanceMore

52 week high40.000 05/02/16
52 week low26.000 28/09/16
52 week change -5.750 (-14.74%)
4 week volume9,269,689 27/12/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Hardman Research: Demanding targets exceeded

RNS Number: 3509U Sinclair Pharma PLC 17 January 2017 Hardman Research: Demanding targets exceeded Demanding targets exceeded - Sinclair is a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products, which target unmet clinical needs for effective, high quality, longer duration, natura...

Sinclair Pharma pleased with FY 2016 performance

Sinclair Pharma is pleased with its 2016 performance, a year when it made excellent progress in its strategy to build a leadi...

Pre-Close Trading Update

RNS Number: 2924U Sinclair Pharma PLC 17 January 2017 Pre-Close Trading Update 37.8 million 12 month revenue to December 31 2016, growth of 51%* Strong performance of all brands Successful US launch of Silhouette Instalift London, 17 January 2017 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, announce...

Notification of full year trading update

Notification of the date financial results will be published

AIM shares touched by the 'Trump effect'

Lots of AIM companies could be affected by Donald Trump's likely policies. Former AIM writer of the year Andrew Hore...

Hardman Research: Poised for a long term uplift

Hardman Research: Poised for a long term uplift

Holding(s) in Company

Notification of major interests in shares

Fundamental DataMore

EPS-1.5
Dividend yield0 %

Equity Research (SPH)

hardman & co
Sinclair Pharma plc
08/11/2016
Sinclair has evolved into a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products. These products target unmet clinical...

Latest discussion posts More

  • More on Nestle - Sinclair link...

    Already an Acquisition Nestle Health Science on Feb. 2 said it acquired CM&D Pharma Ltd., a small U.K. company that develops foods for special medical purposes, primarily ...
    17-Oct-2016
    Ambiorix1
  • Re: Results

    Nestle seems determined to take on its rivals in the dermatology field. A few days ago, Nestle enrolled Allergan executive Paul Navarre, (president of Allergan?s international ...
    14-Oct-2016
    Ambiorix1
  • Re: Results

    ..... and the recent currency movement can surely only help. E
    13-Oct-2016
    Eaglehurst

Users' HoldingsMore

Users who hold Sinclair Pharma also hold..
LLOYDS GRP.37%
BP22%
VODAFONE GRP.19%
BARCLAYS19%
AVIVA18%

Codes & Symbols

ISINGB0033856740
SymbolsSPH, LSE:SPH, SPH.L, SPH:LN, LON:SPH, XLON:SPH